Posted in | News

CECA Makes Acquisition Offer to Arkema To Enhance Activated Carbon Business

Arkema today announced the proposed acquisition by its subsidiary CECA of the "Activated Carbon and Regeneration" business of SNF Italia, a subsidiary of the SNF FLOERGER group. This activity, based in Italy, achieves annual sales of the order of €4 M in the European environment market.

"This acquisition is an excellent opportunity for CECA to consolidate its leading ranking in Southern Europe in the Activated Carbon business for the environment, in particular the treatment of water and air", states Christophe Villain, Managing Director of CECA. "With the transfer of the commercial activity of SNF to the CECA Legnago plant near Verona, the largest in Southern Europe, this operation represents genuine added value for our activated carbon, marketed under the tradename Acticarbone®."

This acquisition will strengthen CECA’s expertise and supply in activated carbon regeneration. Activated carbon regeneration consists of a high temperature process which destroys the organic pollutants trapped as part of the treatment of the air or water. The process restores the initial effectiveness of the activated carbon without producing waste. Regeneration is therefore an innovative and ecological solution, which is also cost-effective for industrialists in the treatment of air and water; this was the route chosen recently by the municipality of Venice.

CECA’s activated carbon is obtained from vegetable material, i.e. various ligneous sources including pinewood and coconut. They are part of the Arkema product range derived from renewable raw materials labelled "Arkema Renewables".

The projet is subject to the approval of the competition authorities in the countries concerned.

Posted April 10th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.